Annual D&A
$108.40 K
+$3000.00+2.85%
31 December 2023
Summary:
BioNexus Gene Lab annual depreciation & amortization is currently $108.40 thousand, with the most recent change of +$3000.00 (+2.85%) on 31 December 2023. During the last 3 years, it has risen by +$6800.00 (+6.69%). BGLC annual D&A is now at all-time high.BGLC Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$49.10 K
+$17.60 K+55.87%
30 September 2024
Summary:
BioNexus Gene Lab quarterly depreciation & amortization is currently $49.10 thousand, with the most recent change of +$17.60 thousand (+55.87%) on 30 September 2024. Over the past year, it has increased by +$19.80 thousand (+67.58%). BGLC quarterly D&A is now -21.82% below its all-time high of $62.80 thousand, reached on 01 December 2020.BGLC Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$139.90 K
+$19.80 K+16.49%
30 September 2024
Summary:
BioNexus Gene Lab TTM depreciation & amortization is currently $139.90 thousand, with the most recent change of +$19.80 thousand (+16.49%) on 30 September 2024. Over the past year, it has increased by +$35.00 thousand (+33.37%). BGLC TTM D&A is now -3.18% below its all-time high of $144.50 thousand, reached on 01 September 2021.BGLC TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BGLC Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.9% | +67.6% | +33.4% |
| 3 y3 years | +6.7% | +83.2% | -3.2% |
| 5 y5 years | +167.0% | +376.7% | +347.0% |
BGLC Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +6.7% | at high | +99.6% | -3.2% | +38.0% |
| 5 y | 5 years | at high | +167.0% | -21.8% | +376.7% | -3.2% | +347.0% |
| alltime | all time | at high | +167.0% | -21.8% | +376.7% | -3.2% | +1219.8% |
BioNexus Gene Lab Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $49.10 K(+55.9%) | $139.90 K(+16.5%) |
| June 2024 | - | $31.50 K(+6.4%) | $120.10 K(+6.1%) |
| Mar 2024 | - | $29.60 K(-0.3%) | $113.20 K(+4.3%) |
| Dec 2023 | $108.40 K(+2.8%) | $29.70 K(+1.4%) | $108.50 K(+3.4%) |
| Sept 2023 | - | $29.30 K(+19.1%) | $104.90 K(+3.5%) |
| June 2023 | - | $24.60 K(-1.2%) | $101.40 K(-2.2%) |
| Mar 2023 | - | $24.90 K(-4.6%) | $103.70 K(-1.6%) |
| Dec 2022 | $105.40 K(-2.6%) | $26.10 K(+1.2%) | $105.40 K(-0.4%) |
| Sept 2022 | - | $25.80 K(-4.1%) | $105.80 K(-0.9%) |
| June 2022 | - | $26.90 K(+1.1%) | $106.80 K(-10.8%) |
| Mar 2022 | - | $26.60 K(+0.4%) | $119.70 K(+10.6%) |
| Dec 2021 | $108.20 K | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | $26.50 K(-1.1%) | $108.20 K(-25.1%) |
| Sept 2021 | - | $26.80 K(-32.7%) | $144.50 K(+10.3%) |
| June 2021 | - | $39.80 K(+163.6%) | $131.00 K(+26.6%) |
| Mar 2021 | - | $15.10 K(-76.0%) | $103.50 K(+2.0%) |
| Dec 2020 | $101.60 K(+90.6%) | $62.80 K(+372.2%) | $101.50 K(+67.2%) |
| Sept 2020 | - | $13.30 K(+8.1%) | $60.70 K(+5.2%) |
| June 2020 | - | $12.30 K(-6.1%) | $57.70 K(+3.4%) |
| Mar 2020 | - | $13.10 K(-40.5%) | $55.80 K(+4.7%) |
| Dec 2019 | $53.30 K(+31.3%) | $22.00 K(+113.6%) | $53.30 K(+70.3%) |
| Sept 2019 | - | $10.30 K(-1.0%) | $31.30 K(+49.0%) |
| June 2019 | - | $10.40 K(-1.9%) | $21.00 K(+98.1%) |
| Mar 2019 | - | $10.60 K | $10.60 K |
| Dec 2018 | $40.60 K | - | - |
FAQ
- What is BioNexus Gene Lab annual depreciation & amortization?
- What is the all time high annual D&A for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual D&A year-on-year change?
- What is BioNexus Gene Lab quarterly depreciation & amortization?
- What is the all time high quarterly D&A for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly D&A year-on-year change?
- What is BioNexus Gene Lab TTM depreciation & amortization?
- What is the all time high TTM D&A for BioNexus Gene Lab?
- What is BioNexus Gene Lab TTM D&A year-on-year change?
What is BioNexus Gene Lab annual depreciation & amortization?
The current annual D&A of BGLC is $108.40 K
What is the all time high annual D&A for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual depreciation & amortization is $108.40 K
What is BioNexus Gene Lab annual D&A year-on-year change?
Over the past year, BGLC annual depreciation & amortization has changed by +$3000.00 (+2.85%)
What is BioNexus Gene Lab quarterly depreciation & amortization?
The current quarterly D&A of BGLC is $49.10 K
What is the all time high quarterly D&A for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly depreciation & amortization is $62.80 K
What is BioNexus Gene Lab quarterly D&A year-on-year change?
Over the past year, BGLC quarterly depreciation & amortization has changed by +$19.80 K (+67.58%)
What is BioNexus Gene Lab TTM depreciation & amortization?
The current TTM D&A of BGLC is $139.90 K
What is the all time high TTM D&A for BioNexus Gene Lab?
BioNexus Gene Lab all-time high TTM depreciation & amortization is $144.50 K
What is BioNexus Gene Lab TTM D&A year-on-year change?
Over the past year, BGLC TTM depreciation & amortization has changed by +$35.00 K (+33.37%)